A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization.
about
Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin ADopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2Heteromeric association creates a P2Y-like adenosine receptorSerotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressedA cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G proteinStructural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at WorkQuantitative codon optimisation of DNA libraries encoding sub-random peptides: design and characterisation of a novel library encoding transmembrane domain peptidesHomo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).Pharmacology of signaling induced by dopamine D(1)-like receptor activationTransmembrane protein aptamers that inhibit CCR5 expression and HIV coreceptor functionAlternative transcripts and evidence of imprinting of GNAL on 18p11.2.The SCHOOL of nature: III. From mechanistic understanding to novel therapiesHomo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis.Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticlesCoactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs.Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83.The G protein-coupled receptors: pharmacogenetics and disease.Modulation of cell function by small transmembrane proteins modeled on the bovine papillomavirus E5 protein.Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases.New therapeutic strategies targeting transmembrane signal transduction in the immune system.Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin ReceptorsDesign of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.Specificity of olfactory receptor interactions with other G protein-coupled receptors.Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition.D2/D3 dopamine receptor heterodimers exhibit unique functional properties.Ligand-independent CXCR2 dimerization.Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor.Physicochemical modulation of agonist-induced [35s]GTPgammaS binding: implications for coexistence of multiple functional conformations of dopamine D1-like receptors.GGIP: Structure and sequence-based GPCR-GPCR interaction pair predictor.G protein-coupled receptor oligomerization for what?
P2860
Q24604923-7CE0AFDD-CA2D-4D6C-BF1B-C7450B6A4342Q24620977-B17E98B0-988E-4368-8702-7499BC26FE59Q24629017-5124EAE1-9F4E-409B-B45B-68E1DB6AADE5Q28371036-5F709E01-8DD2-42A5-942A-E1194D5DD331Q28580583-C4A581B8-ED87-49B0-AD61-EC60833FEBE7Q30401802-14D565AC-75FD-4207-A526-F53D8B44BEF1Q30872906-C867A3B4-9DDC-4568-986F-D340580F6961Q31777917-122B3365-8A56-4AD9-A784-9A5A5A16E7CEQ34126949-6AD5E0D6-0836-4E87-A784-3144EA50E31CQ34343448-3D92874B-F402-4B2F-AAFE-6BE72606E27DQ34437042-2D33B9C3-F2AD-4828-909C-3F2DFFD7B9DCQ34619705-FBCC86EA-C920-48D4-ADCE-1A01C998C068Q34748827-A0F7790F-AD7A-49A7-865A-455CE4C8677AQ35049224-2942A94F-86A3-4D8B-89A7-3874EDA5C3C6Q35923169-2BF15153-45C8-45F0-8808-927F1043B363Q36218464-D3CFA66A-6F7D-462B-B105-CFC2110A5C28Q36310854-DE24F2C4-89EF-47E6-9F81-40080F9776FDQ36318177-5DAED620-8DB3-4461-8424-1DB0CC061F7AQ36822598-82F1C84F-6CCF-4D42-A243-8F5A4C316001Q36978929-690C6E4B-10A8-42EC-94A4-71D405D9AC6FQ37739764-97B00FF4-B6C4-47E1-8A6E-004648648CEAQ37762389-E8F78C36-2CDB-4EC3-A2F4-61C37E2037E3Q38166623-EB74B35C-081F-4FBB-A39C-5C5F7E06AE82Q38315100-98590D40-5827-4FFD-BD28-93729D735E81Q40138581-386FCA0D-919C-4179-9522-D1FD26870B46Q40774825-A94A0430-16A5-4BAD-975C-A5683FE54012Q41268689-73606858-94FD-4696-89B4-6869AA20A735Q43617477-EBB4BD0E-3B1B-40B3-8B64-727D27C51CF5Q44530891-0DF7CDA2-60EE-4317-A7A4-9711A3BEACF6Q44594094-065F75BA-DE5B-4515-91A6-823C2C20462DQ46692544-3FEC82AB-D4E5-419A-A3AC-3D9E6B5D9812Q50643791-5C94FED4-CC63-43CF-954F-34E756E4D5BDQ57781319-F19D9D54-BADC-4FE1-837D-408787B26D14
P2860
A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A transmembrane domain-derived ...... ting receptor oligomerization.
@en
A transmembrane domain-derived ...... ting receptor oligomerization.
@nl
type
label
A transmembrane domain-derived ...... ting receptor oligomerization.
@en
A transmembrane domain-derived ...... ting receptor oligomerization.
@nl
prefLabel
A transmembrane domain-derived ...... ting receptor oligomerization.
@en
A transmembrane domain-derived ...... ting receptor oligomerization.
@nl
P2093
P2860
P356
P1476
A transmembrane domain-derived ...... ting receptor oligomerization.
@en
P2093
Varghese G
P2860
P304
30244-30248
P356
10.1074/JBC.273.46.30244
P407
P577
1998-11-01T00:00:00Z